Filing Details
- Accession Number:
- 0001127602-24-022003
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-08-12 16:13:23
- Reporting Period:
- 2024-08-08
- Accepted Time:
- 2024-08-12 16:13:23
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1100682 | Charles River Laboratories International Inc. | CRL | Services-Commercial Physical & Biological Research (8731) | 061397316 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1767215 | W Joseph Laplume | C/O Charles River Laboratories 251 Ballardvale Street Wilmington MA 01887 | Evp, Corp Strategy & Develop | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2024-08-08 | 1,780 | $199.36 | 22,521 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Billionaire Hedge Funds
